Fisetin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF

Diabetic retinopathy (DR) is one of the more serious complications of diabetes. However, the mechanisms involved in DR are complex and still need to be investigated. The beneficial effects of fisetin have been widely reported, but whether it is beneficial in DR is not clear yet. This study was desig...

Full description

Bibliographic Details
Main Authors: Meihua Lai, Caifeng Lan, Junmu Zhong, Lijuan Wu, Chengmin Lin
Format: Article
Language:English
Published: Hindawi Limited 2023-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2023/7951928
_version_ 1811165416577302528
author Meihua Lai
Caifeng Lan
Junmu Zhong
Lijuan Wu
Chengmin Lin
author_facet Meihua Lai
Caifeng Lan
Junmu Zhong
Lijuan Wu
Chengmin Lin
author_sort Meihua Lai
collection DOAJ
description Diabetic retinopathy (DR) is one of the more serious complications of diabetes. However, the mechanisms involved in DR are complex and still need to be investigated. The beneficial effects of fisetin have been widely reported, but whether it is beneficial in DR is not clear yet. This study was designed to investigate the regulatory role of fisetin in regulating DR and explore the involved mechanism. First, 30 mM glucose was used to establish DR cell model in vitro. Cell counting kit 8 (CCK8) assay was utilized to study the effects of fisetin on cell viability through treating human retinal microvascular endothelial cells (HRMECs) with 25, 50, and 100 μM fisetin. Transwell and wound healing assays were used to detect the function of fisetin on the migration and angiogenesis on HG-induced HRMECs. Finally, OE-VEGF was used as a mimic of VEGF, and western blotting (WB) was used to verify the targeting genes of fisetin. HG induced an increase in cell viability, cell migration, and angiogenesis in HRMECs, whereas fisetin inhibited these enhancements induced by HG through inhibiting VEGF. In conclusion, fisetin prevents angiogenesis in DR by downregulating VEGF.
first_indexed 2024-04-10T15:37:59Z
format Article
id doaj.art-a18501d2e4d04accb1b1d2eeb3dc0b98
institution Directory Open Access Journal
issn 2090-0058
language English
last_indexed 2024-04-10T15:37:59Z
publishDate 2023-01-01
publisher Hindawi Limited
record_format Article
series Journal of Ophthalmology
spelling doaj.art-a18501d2e4d04accb1b1d2eeb3dc0b982023-02-13T01:09:19ZengHindawi LimitedJournal of Ophthalmology2090-00582023-01-01202310.1155/2023/7951928Fisetin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGFMeihua Lai0Caifeng Lan1Junmu Zhong2Lijuan Wu3Chengmin Lin4Department of OphthalmologyDepartment of UltrasonographyDepartment of OphthalmologyDepartment of OphthalmologyDepartment of OphthalmologyDiabetic retinopathy (DR) is one of the more serious complications of diabetes. However, the mechanisms involved in DR are complex and still need to be investigated. The beneficial effects of fisetin have been widely reported, but whether it is beneficial in DR is not clear yet. This study was designed to investigate the regulatory role of fisetin in regulating DR and explore the involved mechanism. First, 30 mM glucose was used to establish DR cell model in vitro. Cell counting kit 8 (CCK8) assay was utilized to study the effects of fisetin on cell viability through treating human retinal microvascular endothelial cells (HRMECs) with 25, 50, and 100 μM fisetin. Transwell and wound healing assays were used to detect the function of fisetin on the migration and angiogenesis on HG-induced HRMECs. Finally, OE-VEGF was used as a mimic of VEGF, and western blotting (WB) was used to verify the targeting genes of fisetin. HG induced an increase in cell viability, cell migration, and angiogenesis in HRMECs, whereas fisetin inhibited these enhancements induced by HG through inhibiting VEGF. In conclusion, fisetin prevents angiogenesis in DR by downregulating VEGF.http://dx.doi.org/10.1155/2023/7951928
spellingShingle Meihua Lai
Caifeng Lan
Junmu Zhong
Lijuan Wu
Chengmin Lin
Fisetin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF
Journal of Ophthalmology
title Fisetin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF
title_full Fisetin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF
title_fullStr Fisetin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF
title_full_unstemmed Fisetin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF
title_short Fisetin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF
title_sort fisetin prevents angiogenesis in diabetic retinopathy by downregulating vegf
url http://dx.doi.org/10.1155/2023/7951928
work_keys_str_mv AT meihualai fisetinpreventsangiogenesisindiabeticretinopathybydownregulatingvegf
AT caifenglan fisetinpreventsangiogenesisindiabeticretinopathybydownregulatingvegf
AT junmuzhong fisetinpreventsangiogenesisindiabeticretinopathybydownregulatingvegf
AT lijuanwu fisetinpreventsangiogenesisindiabeticretinopathybydownregulatingvegf
AT chengminlin fisetinpreventsangiogenesisindiabeticretinopathybydownregulatingvegf